Melatonin in Schizophrenic Outpatients With Insomnia: A Double-Blind, Placebo-Controlled Study
The DOI matches its Crossref record.
Abstract
BACKGROUND: Low nighttime levels of melatonin have been demonstrated in patients with insomnia, and melatonin has been shown to have hypnotic properties in some groups of such subjects. Low melatonin levels have also been observed in patients with schizophrenia; however, there is little literature on the efficacy of exogenous melatonin in treating insomnia associated with schizophrenia. METHOD: Stable DSM-IV schizophrenic outpatients (N = 40) with initial insomnia of at least 2 weeks' duration were randomly assigned to augment their current medications with either flexibly dosed melatonin (3-12 mg/night; N = 20) or placebo (N = 20). By use of a questionnaire, double-blind assessments of aspects of sleep functioning were obtained daily across the next 15 days. The study was conducted between March and December 2002. RESULTS: The modal stable dose of melatonin was 3 mg. Relative to placebo, melatonin significantly improved the quality and depth of nighttime sleep, reduced the number of nighttime awakenings, and increased the duration of sleep without producing a morning hangover (p < .05). Subjectively, melatonin also significantly reduced sleep-onset latency, heightened freshness on awakening, improved mood, and improved daytime functioning (p < .05). CONCLUSION: Melatonin may be a useful short-term hypnotic for schizophrenic patients with insomnia. Melatonin could be considered for patients in whom conventional hypnotic drug therapy or higher sedative antipsychotic drug doses may be problematic.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“although neither investigated the effect of this treatment with psychotic experiences.”
From The role of sleep dysfunction in the occurrence of delusions and hallucinations: A systematic review (2015) · cites this paper as Kumar et al., 2007
In the citing paper
“Two small RCTs have indicated that melatonin supplements improve sleep quality in patients with schizophrenia (Kumar et al., 2007, Shamir et al., 2000) although neither investigated the effect of this treatment with psychotic experiences.”
From The role of sleep dysfunction in the occurrence of delusions and hallucinations: A systematic review (2015) · cites this paper as Kumar et al., 2007
Citations
Cites
Still being checked.
Cited by
The role of sleep dysfunction in the occurrence of delusions and hallucinations: A systematic review
Reeve, S., Sheaves, B., & Freeman, D. (2015) · Clinical Psychology Review · doi:10.1016/j.cpr.2015.09.001 · Cited by 273
Schizophrenia and sleep disorders: links, risks, and management challenges
Kaskie, R., Graziano, B., & Ferrarelli, F. (2017) · Nature and Science of Sleep · doi:10.2147/nss.s121076 · Cited by 196
Sleep and circadian rhythm dysregulation in schizophrenia
Monti, J. M., BaHammam, A. S., Pandi-Perumal, S. R., Bromundt, V., Spence, D. W., Cardinali, D. P., & Brown, G. M. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.12.021 · Cited by 157
“Suresh Kumar et al. (2007) reported that melatonin improved the subjective quality of sleep in a randomized, double-blinded, placebo-controlled trial including 40 stable DSM-IV schizophrenic outpatients with initial insomnia of at least 2 weeks' duration.”
Therapeutic Effects of Melatonin Receptor Agonists on Sleep and Comorbid Disorders
Laudon, M., & Frydman-Marom, A. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150915924 · Cited by 149
Update on Sleep and Psychiatric Disorders
Sateia, M. J. (2009) · CHEST Journal · doi:10.1378/chest.08-1834 · Cited by 159
Metadata
- Authors
- Kumar, P. N. S., Andrade, C., Bhakta, S. G., & Singh, N. M.
- Affiliations
- Institute of Mental Health and Neurosciences (IN)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2007-02-15
- Volume
- 68
- Issue
- 02
- Pages
- 237-241
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2039096770
- Cited by
- 102
- References
- 0
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 1 · 2023: 2 · 2022: 6 · 2021: 6 · 2020: 7 · 2019: 7 · 2018: 5 · 2017: 5 · 2016: 7 · 2015: 6 · 2014: 4 · 2013: 9 · 2012: 5
- FWCI
- 6.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- melatonin, insomnia, schizophrenia, hypnotic treatment, sleep quality, sleep latency, nocturnal awakenings, antipsychotic adverse effects, daytime functioning
- MeSH terms
- Adult, Dose-Response Relationship, Drug, Double-Blind Method, Female, Humans, Hypnotics and Sedatives, Sleep Initiation and Maintenance Disorders, Male, Melatonin, Middle Aged, Schizophrenia, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Melatonin in Schizophrenic Outpatients With Insomnia: A Double-Blind, Placebo-Controlled Study. https://app.cochat.ai/papers/10.4088/jcp.v68n0208
- The paper
- Kumar, P. N. S., Andrade, C., Bhakta, S. G., & Singh, N. M. (2007). Melatonin in Schizophrenic Outpatients With Insomnia: A Double-Blind, Placebo-Controlled Study. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.v68n0208
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.